Skip to main content

Table 2 Mutation rate for different kind of body fluid samples in our clinical practice using sequencing

From: A comparison of ARMS and direct sequencing for EGFR mutation analysis and Tyrosine Kinase Inhibitors treatment prediction in body fluid samples of Non-Small-Cell Lung Cancer patients

 

Pleural fluid

Plasma

Total

Total

142

78

220

19-del

18

2

20

L858R

15

2

17

Mutation rate (%)

23.2

5.1

16.8

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us